Loading...

MRNA MODERNA INC Earnings Reports 8-K Filing

MDRN

MRN

MODERNA INC

(MRNA)

2024 8-K

Settlement Agreement

Financial Results

FDA Rejection Letter

Financial Update

Shareholder Letter

Credit Agreement Signed

Pipeline Update

Shareholder Meeting Results

Financial Results Announcement

Financial Statements

Financial Statements

Financial Results

Financial Results

Q3 Financial Results

Board Appointment

Investor Updates

Earnings Reports

Resignation and Appointment

Amendments to Certificate o...

Earnings Reports

Financial Results Announcement

Financial Results

Departure of Chief Commerci...

Management Change

Earnings Reports

Earnings Reports

Financial Results Announcement

Annual Meeting Voting Results

Financial Results Announcement

Financial Results Announcement

Financial Results

Regulation FD Disclosure

External Links:

Moderna, Inc. issued a press release with preliminary financial information for the fiscal year ended December 31, 2023, stating $6.7 billion in product sales and over $13 billion in cash, cash equivalents, and investments.

AI Assistant

MODERNA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.